Keratosis follicularis-dwarfism-cerebral atrophy syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Keratosis follicularis-dwarfism-cerebral atrophy syndrome
Synonyms	KFDCA syndrome
Pronounce	N/A
Specialty	Medical genetics
Symptoms	Keratosis follicularis, dwarfism, cerebral atrophy
Complications	N/A
Onset	Childhood
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks	Family history
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis	Other genetic disorders
Prevention	N/A
Treatment	Symptomatic management
Medication	N/A
Prognosis	Variable
Frequency	Rare
Deaths	N/A

Keratosis follicularis-dwarfism-cerebral atrophy syndrome is a rare genetic disorder characterized by the triad of keratosis follicularis, dwarfism, and cerebral atrophy. It follows an X-linked recessive inheritance pattern, meaning it predominantly affects males, while females are typically carriers. The condition is diagnosed through a combination of genetic testing and clinical evaluation. Management is primarily symptomatic, focusing on addressing the individual symptoms associated with the syndrome. The prognosis varies depending on the severity of the symptoms and the effectiveness of the management strategies employed.

Rare genetic disorder

Keratosis follicularis-dwarfism-cerebral atrophy syndrome is a rare genetic disorder characterized by a combination of skin, growth, and neurological abnormalities. This condition is inherited in an X-linked recessive pattern, primarily affecting males, while females are typically carriers.

Clinical Features

The syndrome presents with a triad of clinical features:

Keratosis Follicularis

Individuals with this syndrome exhibit keratosis follicularis, a skin condition marked by the development of small, rough bumps on the skin due to the accumulation of keratin in hair follicles. These lesions are often widespread and can be cosmetically concerning.

Dwarfism

Dwarfism in this context refers to significantly reduced growth and short stature. Affected individuals may have a height well below the average for their age and sex, often due to a combination of skeletal dysplasia and other growth impairments.

Cerebral Atrophy

Cerebral atrophy involves the progressive loss of neurons and the connections between them. This can lead to a variety of neurological symptoms, including developmental delays, intellectual disability, and motor skill impairments. The degree of cerebral atrophy can vary among individuals.

Genetics

The syndrome is caused by mutations in a gene located on the X chromosome. As an X-linked recessive disorder, males are more frequently affected because they have only one X chromosome. Females, with two X chromosomes, are usually carriers and may exhibit mild symptoms due to X-inactivation.

Diagnosis

Diagnosis of keratosis follicularis-dwarfism-cerebral atrophy syndrome is based on clinical evaluation, family history, and genetic testing. Dermatological examination, growth assessments, and neuroimaging studies such as MRI can aid in identifying the characteristic features of the syndrome.

Management

There is no cure for this syndrome, and management is primarily supportive and symptomatic. Dermatological treatments may include topical keratolytics for skin lesions. Growth hormone therapy might be considered for short stature, although its effectiveness can vary. Neurological symptoms are managed through physical therapy, occupational therapy, and educational support.

Prognosis

The prognosis for individuals with this syndrome depends on the severity of the symptoms. While skin and growth issues can be managed to some extent, neurological impairments may significantly impact quality of life and require ongoing support.

See also

• X-linked recessive inheritance
• Keratosis follicularis
• Dwarfism
• Cerebral atrophy